Recure Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -12.51%
(FY 2022)
- Profit 89.96%
(FY 2022)
- Ebitda -355.56%
(FY 2022)
- Net Worth -0.57%
(FY 2022)
- Total Assets 9.79%
(FY 2022)
About Recure Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kunal Dangaria, Bharat Solanki, Harsh Rathod, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100GJ2013PTC075860
- Company No.
075860
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Recure Healthcare Private Limited offer?
Recure Healthcare Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement.
Who are the key members and board of directors at Recure Healthcare?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harsh Rathod | Director | 05-Jun-2019 | Current |
Bharat Solanki | Director | 21-May-2014 | Current |
Kunal Dangaria | Director | 21-May-2014 | Current |
Pankajbhai Rathod | Director | 27-Nov-2017 | Current |
Financial Performance of Recure Healthcare.
Recure Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.51% decrease. The company also saw a substantial improvement in profitability, with a 89.96% increase in profit. The company's net worth dipped by a decrease of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Recure Healthcare?
In 2018, Recure Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Blossom Kitchenware Pvt LtdActive 34 years 11 months
Harsh Rathod and Pankajbhai Rathod are mutual person
- Bioszorg Meditech Private LimitedInactive For E-Filing 4 months 19 days
Bharat Solanki is a mutual person
- Ai Sante Meditech Private LimitedInactive For E-Filing 4 months 19 days
Bharat Solanki is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Recure Healthcare?
Unlock and access historical data on people associated with Recure Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recure Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recure Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.